SAN
86.26
-0.06%↓
ARGX
782.2
-0.23%↓
PHIA
23.99
+1.14%↑
ONC.US
335.23
+1.26%↑
FME
41.75
+1.36%↑
SAN
86.26
-0.06%↓
ARGX
782.2
-0.23%↓
PHIA
23.99
+1.14%↑
ONC.US
335.23
+1.26%↑
FME
41.75
+1.36%↑
SAN
86.26
-0.06%↓
ARGX
782.2
-0.23%↓
PHIA
23.99
+1.14%↑
ONC.US
335.23
+1.26%↑
FME
41.75
+1.36%↑
SAN
86.26
-0.06%↓
ARGX
782.2
-0.23%↓
PHIA
23.99
+1.14%↑
ONC.US
335.23
+1.26%↑
FME
41.75
+1.36%↑
SAN
86.26
-0.06%↓
ARGX
782.2
-0.23%↓
PHIA
23.99
+1.14%↑
ONC.US
335.23
+1.26%↑
FME
41.75
+1.36%↑
24h
Aktuell
Min
111.75
Max
116.05
Einkommen | 250M 902M |
|---|---|
Verkäufe | 63M 5.3B |
EPS | 2.07 |
Dividendenrendite | 1.34 |
Gewinnspanne | 16.961 |
Empfehlungen | Buy |
|---|---|
12-Monats-Prognose | +24.62% upside |
Dividendenrendite Branchendurchschnitt | 1.34% 2.31% |
|---|
Marktkapitalisierung | 98B |
|---|---|
Vorheriger Eröffnungskurs | 113.11 |
Vorheriger Schlusskurs | 115.55 |
By Acuity
21%
79%
39 / 374 Ranking in Healthcare
By Trading Central
Vertrauen
Strong Bearish Evidence
121.15 / 123.55 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
13. Nov. 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Lesen
13. Nov. 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Lesen
1. Okt. 2025, 08:54 UTC
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
DJ
Lesen
13. Nov. 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B
DJ
Lesen
13. Nov. 2025, 06:00 UTC
Merck KGaA 3Q Sales EUR5.32B
DJ
Lesen
6. Nov. 2025, 21:52 UTC
Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED
DJ
Lesen
6. Nov. 2025, 21:51 UTC
Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany
DJ
Lesen
16. Okt. 2025, 08:34 UTC
Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk
DJ
Lesen
15. Okt. 2025, 12:08 UTC
Merck KGaA Didn't Disclose Financial Details
DJ
Lesen
15. Okt. 2025, 12:07 UTC
Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio
DJ
Lesen
15. Okt. 2025, 12:07 UTC
Merck KGaA: Unit is Based in Belgium, Has 50+ Employees
DJ
Lesen
15. Okt. 2025, 12:06 UTC
Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market
DJ
Lesen
15. Okt. 2025, 12:05 UTC
Merck KGaA: Definitive Agreement Signed Today
DJ
Lesen
15. Okt. 2025, 12:05 UTC
Merck KGaA: Transaction Expected to Close by End of 2Q 2026
DJ
Lesen
15. Okt. 2025, 12:04 UTC
Merck KGaA to Buy Chromatography Business JSR Life Sciences
DJ
Lesen
15. Okt. 2025, 12:03 UTC
Merck KGaA to Buy Chromatography Business of JSR Life Sciences
DJ
Lesen
7. Aug. 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 140.57 EUR 24.62%
Hoch 182 EUR
Tief 105 EUR
Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Merck KGaA – Dist angeboten haben.
By TipRanks
Buy
8 ratings
5
Buy
2
Halten
1
Sell
Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Merck KGaA – Dist abgegeben haben.
By Trading Central
Kurzfristig
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Neutral Evidence
The bullish and bearish events are balanced.
Langfristig
Bearish Evidence
All events are bearish.
By Acuity
Nachrichtenstimmung
Sehr starke bullische Evidenz
Volatilität
Unterdurchschnittlich
Nachrichtenvolumen (RCV)
Überdurchschnittlich
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$